scholarly journals Agave Inulin Supplementation Affects the Fecal Microbiota of Healthy Adults Participating in a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

2015 ◽  
Vol 145 (9) ◽  
pp. 2025-2032 ◽  
Author(s):  
Hannah D Holscher ◽  
Laura L Bauer ◽  
Vishnupriya Gourineni ◽  
Christine L Pelkman ◽  
George C Fahey ◽  
...  
2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1570-1570
Author(s):  
Annemarie Krug ◽  
Corinne Cannavale ◽  
Naiman Khan ◽  
Hannah Holscher

Abstract Objectives Prebiotics are defined as substrates that are selectively utilized by host microorganisms conferring a health benefit. We aimed to determine the effects of the prebiotics fructooligosaccharides (FOS) and galactooligosaccharides (GOS) on the fecal microbiota and gastrointestinal health in adults. Methods We conducted a randomized, double-blind, placebo-controlled, crossover trial in healthy adults (n = 26) 25–45 years of age. Participants consumed two 4-week treatments in a randomized, counterbalanced order. The prebiotic beverage (PRE) was 8 oz low-fat lactose-free milk with 5 g FOS and 5 g GOS. The control beverage (CON) was 8 oz low-fat lactose-free milk without the added prebiotics. Each condition was separated by a 4-week washout. Fecal samples were collected at baseline and end of each condition. Fecal short-chain fatty acid (SCFA) concentrations were quantified using gas chromatography-mass spectrometry (GC-MS). Fecal pH was measured using a pH meter. Gastrointestinal health was assessed using the Bristol stool scale and a stool frequency and ease of passage log before the first and during the last week of each condition. SAS 9.4 was used to conduct general linear mixed modeling with treatment as a fixed effect and participant and period as random effects. Normality was assessed using the Shapiro-Wilk test and log and arcsine transformations were applied as needed. Results There was a 153% increase in fecal bifidobacteria relative abundances in the prebiotic group compared to control (CON: 2.8 ± 0.6, PRE: 6.9 ± 1.7; P = 0.002). No differences were detected between the groups in fecal acetate (CON: 278 ± 30.1, PRE: 231 ± 24.4; P = 0.2), butyrate (CON: 68.4 ± 10.1, PRE: 62.9 ± 12.2; P = 0.4), or propionate (CON: 76.5 ± 7.5, PRE: 76.7 ± 12.5; P = 0.4) concentrations, or fecal pH (CON: 6.86 ± 0.10, PRE: 6.91 ± 0.14; P = 0.5). Stool frequency (stool/day) increased by 26% in PRE compared to CON (CON: 1.0 ± 0.1, PRE: 1.3 ± 0.1; P = 0.01). Ease of stool passage tended to improve in PRE compared to CON (CON: 2.2 ± 0.1, PRE: 2.0 ± 0.1; P = 0.1). There was no difference in stool consistency (CON: 3.7 ± 0.3, PRE: 3.7 ± 0.2; P = 0.8). Conclusions These findings are suggestive of the beneficial health effects of consumption of the prebiotics FOS and GOS on gastrointestinal health in adults. Funding Sources USDA National Institute of Food and Agriculture, Hatch Project 1009249.


2021 ◽  
Vol 35 (S1) ◽  
Author(s):  
Aouatef Bellamine ◽  
Sailendharan Sudakaran ◽  
Traci Blonquist ◽  
Eucine Mah ◽  
Shane Durkee ◽  
...  

Nutrition ◽  
2021 ◽  
pp. 111273
Author(s):  
Oliver Chen ◽  
Sailendharan Sudakaran ◽  
Traci Blonquist ◽  
Eunice Mah ◽  
Shane Durkee ◽  
...  

2006 ◽  
Vol 95 (6) ◽  
pp. 1143-1149 ◽  
Author(s):  
Petra A. M. J. Scholtens ◽  
Martine S. Alles ◽  
Linette E. M. Willemsen ◽  
Claudia van den Braak ◽  
Jacques G. Bindels ◽  
...  

Fructo-oligosaccharides (FOS) are widely used in commercial food products. Most studies on FOS concern the health benefits, but some negative effects were recently reported concerning thefaecal cytotoxicity and excretion of mucin-type oligosaccharides in combination with a Ca-restricted diet. The present study was performed to investigate whether these effects of FOS are observed in adults consuming a regular diet unrestricted in Ca. The study was a randomised, double-blind, placebo-controlled crossover trial, involving eleven healthy adults, who consumed 25–30g FOS or maltodextrin (control) in a random order for 2 weeks in addition to their regular diet. Stools were collected for analysis of pH and SCFA (as markers of fermentation), for the assessment of faecal water cytotoxicity, and for the analysis of alkaline phosphataseactivity (as a marker of epithelial cell turnover) andO-linked oligosaccharides (to estimate the excretion of mucin-type oligosaccharides). FOS consumption significantly altered bacterial fermentation (increased percentage of acetate, decreased percentage of butyrate) and tended to decrease stool pH. Furthermore, FOS consumption resulted in a significantly higher stool frequency and in significantly more complaints of flatulence. No significant differences between the control and FOS period were observed in the mean cytotoxicity of faecal water (37·5 (sem 6·9) % v. 18·5 (sem 6·9) % P=0·084), in mean alkaline phosphatase activity (27·7 (sem 2·9) v. 24·6 (sem 3·2) U/g dry faeces; P=0·496) or in the mean excretion of mucin-type oligosaccharides (49·9 (sem 4·0)v. 53·5 (sem 4·3) mg/g dry faeces; P=0·553). We conclude that dietary FOS in a dose up to 25–30g/d altered the bacterial fermentation pattern but did not affect faecal cytotoxicity or the faecal concentration of mucin-type oligosaccharides in human adults consuming a regular diet.


2021 ◽  
pp. 100895
Author(s):  
Jens Christian Laursen ◽  
Niels Søndergaard-Heinrich ◽  
Joana Mendes Lopes de Melo ◽  
Bryan Haddock ◽  
Ida Kirstine Bull Rasmussen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document